Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BRIEF-Enanta Pharmaceuticals Q3 Revenue USD 14.359 Million Vs. IBES Estimate USD 16.8 Million

BRIEF-Enanta Pharmaceuticals Q3 Revenue USD 14.359 Million Vs. IBES Estimate USD 16.8 Million

ReutersReuters2026/08/10 20:02

Aug 10 (Reuters) - Enanta Pharmaceuticals Q3 net income USD -19.501 million.

  • Q3 operating expenses USD 31.595 million
  • Q3 pretax profit USD -19.465 million
  • Q3 operating income USD -17.236 million
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!